KBC Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,336
| Closed | -$70K | – | 1735 |
|
|
2025
Q1 | $70K | Hold |
2,336
| – | – | ﹤0.01% | 1674 |
|
|
2024
Q4 | $67K | Buy |
2,336
+982
| +73% | +$28.2K | ﹤0.01% | 1752 |
|
|
2024
Q3 | $52K | Hold |
1,354
| – | – | ﹤0.01% | 1690 |
|
|
2024
Q2 | $44K | Hold |
1,354
| – | – | ﹤0.01% | 1687 |
|
|
2024
Q1 | $53K | Hold |
1,354
| – | – | ﹤0.01% | 1519 |
|
|
2023
Q4 | $42K | Sell |
1,354
-285
| -17% | -$8.84K | ﹤0.01% | 1644 |
|
|
2023
Q3 | $37K | Sell |
1,639
-1,102
| -40% | -$24.9K | ﹤0.01% | 1665 |
|
|
2023
Q2 | $59K | Hold |
2,741
| – | – | ﹤0.01% | 1325 |
|
|
2023
Q1 | $66K | Sell |
2,741
-614
| -18% | -$14.8K | ﹤0.01% | 1324 |
|
|
2022
Q4 | $78K | Hold |
3,355
| – | – | ﹤0.01% | 1283 |
|
|
2022
Q3 | $54K | Hold |
3,355
| – | – | ﹤0.01% | 1373 |
|
|
2022
Q2 | $59K | Sell |
3,355
-15,366
| -82% | -$270K | ﹤0.01% | 1387 |
|
|
2022
Q1 | $381K | Hold |
18,721
| – | – | ﹤0.01% | 877 |
|
|
2021
Q4 | $350K | Buy |
18,721
+9,944
| +113% | +$186K | ﹤0.01% | 951 |
|
|
2021
Q3 | $173K | Buy |
+8,777
| New | +$173K | ﹤0.01% | 1091 |
|